Development of a Prediction Model for Delirium After Cardiac Surgery Using a Novel Self-Administered Preoperative Cognitive Assessment Tool
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Dec 1, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a tool called CogCheck, which is a self-administered assessment designed to predict the risk of delirium after heart surgery. Delirium is a condition that can cause confusion and changes in awareness, and it can be a concern for patients after surgery. The goal of this study is to see if the CogCheck app can help identify patients who may be at higher risk for this problem so that doctors can take steps to help prevent it.
To be eligible for this trial, participants must be at least 60 years old, be scheduled for elective heart surgery, and have a good understanding of the German language. They also need to provide written consent to participate. The study is currently looking for volunteers, and those who join can expect to use the CogCheck app to assess their cognitive abilities before their surgery. This could help improve care and outcomes for patients undergoing cardiac surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Elective cardiac surgery
- • Age ≥60 years
- • Good knowledge of the German language
- • Written informed consent
- Exclusion Criteria:
- • Emergency surgery
- • Medical instability limiting preoperative assessment
- • Surgical procedures without the use of cardiopulmonary bypass
- • Procedures involving deep hypothermic circulatory arrest
- • Concurrent carotid surgical procedures
- • Participation in an interventional trial with POD or POCD as primary endpoint
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Luzius Steiner, MD, PhD
Study Chair
University Hospital, Basel, Switzerland
Nicolai Goettel, MD
Principal Investigator
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials